The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates
2017 · Molecular Metabolism · 131 citations
https://doi.org/10.1016/j.molmet.2017.12.007
H
Hanni Willenbrock
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
3.4K
Citations
18
h-index
22
i10-index
Hanni Willenbrock is an academic researcher from Novo Nordisk (Denmark). The author has contributed to research in topics: Genomics and Phylogenetic Studies & MicroRNA in disease regulation & Cancer-related molecular mechanisms research. The author has an h-index of 18, co-authored 32 publications.
Papers by this author
worksCharacterization of probiotic Escherichia coliisolates with a novel pan-genome microarray
2007 · Genome biology · 96 citations
https://doi.org/10.1186/gb-2007-8-12-r267
An environmental signature for 323 microbial genomes based on codon adaptation indices
2006 · Genome biology · 62 citations
https://doi.org/10.1186/gb-2006-7-12-r114
Molecular profiling of stem cell-derived retinal pigment epithelial cell differentiation established for clinical translation
2022 · Stem Cell Reports · 26 citations
https://doi.org/10.1016/j.stemcr.2022.05.005
Clinically compliant cryopreservation of differentiated retinal pigment epithelial cells
2024 · Cytotherapy · 3 citations
https://doi.org/10.1016/j.jcyt.2024.01.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat